Antibodies In Ebola Survivors’ Blood Are ‘Promising Candidates’ For Therapy Development, NIH-Supported Study Shows

NIH: Broadly acting antibodies found in plasma of Ebola survivors
This NIH news release discusses results from research supported by the National Institute of Allergy and Infectious Diseases (NIAID) examining antibodies found in the blood of Ebola survivors. The news release states, “The researchers conclude that these broadly neutralizing antibodies are promising candidates for further development as therapeutic molecules against several ebolavirus species” (7/17).